Pulmonary Artery Pseudoaneurysm Caused by Pulmonary Mucormycosis

🔗 bit.ly/3J8nXB2

Cell-based Therapies for Acute Respiratory Distress Syndrome: Where Are We Now?

The authors critically assess recent clinical studies, and propose a pathway to best assess the therapeutic promise of mesenchymal stromal cell–based therapies for ARDS

🔗 bit.ly/3TGAFvP

The authors explore the link between mechanical power and ventilator-induced lung injury. Energy dissipation from cyclic recruitment likely plays a pivotal role. Understanding this interplay is crucial for lung-protective ventilation.
Donald Gaver

🔗 bit.ly/4cB0UfP

Use of the Win Ratio Analysis in Critical Care Trials

🔗 bit.ly/49kPhH9

Journal Sessions at ATS 2024

Register now: conference.thoracic.org

Association between Age and Mortality in Pediatric and Adult Acute Respiratory Distress Syndrome

🔗 bit.ly/49lezon

Adolescents and Young Adults: An Understudied, yet Likely Informative, Population in ARDS

🔓 Open Access
🔗 bit.ly/4cFINpa

Oxygen-Saturation Targets and Cognitive and Functional Outcomes in Mechanically Ventilated Adults

This study of ICU survivors randomized to high, intermediate, or low oxygen targets found no difference in cognitive outcomes at 12 months
Matthew Mart

🔗 bit.ly/3VI6s20

A New Era in Critical Care Trials: Linking ICU Practice to Long-Term Outcomes

🔓 Open Access
🔗 bit.ly/4aiJ2F7

Heterogeneity of Benefit from Earlier Time-to-Antibiotics for Sepsis

🔗 bit.ly/3PNhf7g

The Blue Journal thanks Bhavesh M. Patel, MD, for his contribution to the April 1 issue
Bhavesh Patel

Association between Age and Mortality in Pediatric and Adult Acute Respiratory Distress Syndrome

bit.ly/4cNb7WJ

Beyond Septic Shock: Who Else Requires Immediate Antibiotics?

🔓 Open Access
🔗 bit.ly/3xkZNkx

The Blue Journal thanks Matthew F. Mart, MD, MSc, for his contribution to the April 1 issue

Oxygen-Saturation Targets and Cognitive and Functional Outcomes in Mechanically Ventilated Adults
Matthew Mart
Jin Ho Han

bit.ly/3VI6s20

AJRCCM Editors Drs. Leo Heunks, Laurent Brochard, and Edward Schenck presented articles from the March 1 issue at the ISICEM 2024 in Brussels

March 1 Issue 🔗 bit.ly/4bUI6YN

SARS-CoV-2 Viral Replication Persists in the Human Lung for Several Weeks after Symptom Onset

🔓 Open Access
🔗 bit.ly/3xlCveh

SARS-CoV-2 Lurking and Lingering in the Depths of Lungs

🔓 Open Access
🔗 bit.ly/3VC2pEB

The Blue Journal thanks Rachel K. Hechtman, MD, for her contribution to the April 1 issue

Heterogeneity of Benefit from Earlier Time-to-Antibiotics for Sepsis
Michigan Medicine Pulmonary & Critical Care 🫁

bit.ly/3PNhf7g

Antimicrobial Drug Penetration Is Enhanced by Lung Tissue Inflammation and Injury

In a unilateral ALI model, increased antimicrobial lung tissue concentrations during acute inflammation support timely antimicrobial treatment in suspected pneumonia

🔗 bit.ly/3VI84sL

Lessons Are Still Being Learned about Intrapulmonary Antibiotic Concentrations

🔓 Open Access
🔗 bit.ly/3xufvti

The Blue Journal thanks Johannes Geilen, MD, for his contribution to the April 1 issue

Antimicrobial Drug Penetration Is Enhanced by Lung Tissue Inflammation and Injury
bit.ly/3VI84sL